NCT00807495View on ClinicalTrials.gov

Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 10, 2009

Primary Completion Date

January 4, 2011

Study Completion Date

February 13, 2013

Conditions
Diffuse Large B-cell LymphomaMantle Cell LymphomaBurkitt's LymphomaT-cell Lymphoma, Excluding Primary Cutaneous T-cell LymphomaTransformed Follicular Lymphoma With ≥ 50% Diffuse Large Cell Component
Interventions
DRUG

Alisertib

Alisertib capsules

Trial Locations (1)

08060

Hematology Oncology Associates, Virtua Memorial Hospital Burlington County, Mount Holly

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY